Document Report Card

ID: ALA1150353

Journal: J Med Chem

Title: Development of novel antiatherogenic biaryls: design, synthesis, and reactivity.

Authors: Delomenède M, Bedos-Belval F, Duran H, Vindis C, Baltas M, Nègre-Salvayre A.

Abstract: On the basis of the 5,5'-bisvanillin scaffold, a series of compounds has been synthesized presenting symmetric or dissymmetric frames on each phenolic moiety. These frames are alpha,beta-unsaturated (fluoro)phosphonate and/or alpha,beta-unsaturated hydrazone(s) formed by coupling aldehydic with isoniazid or hydralazine. All compounds were tested for their ability to inhibit cell-mediated low-density lipoprotein oxidation. Oxidized low-density lipoprotein induced cytotoxicity was also evaluated along with the carbonyl scavenger properties of selected compounds. The most efficient agents were found to be those possessing at least one hydralazinone frame, with the most potent being the symmetrical compound: 4,4'-dihydroxy-3,3'-dimethoxy-5,5'-biphenyl-1,1'-(diphthalazin-1-yl)methylhydrazone hydrochloride.

CiteXplore: 18465848

DOI: 10.1021/jm7014793